Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001968364 | SCV002239387 | uncertain significance | not provided | 2021-09-18 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine with valine at codon 286 of the POLE2 protein (p.Met286Val). The methionine residue is moderately conserved and there is a small physicochemical difference between methionine and valine. This variant is present in population databases (rs368277605, ExAC 0.01%). This missense change has been observed in individual(s) with colorectal cancer (PMID: 32449991). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |